Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

The International Society for Immunopharmacology's Invitation to Join

Gregor Mendel* and Dmitri Mendeleev

The field of immunopharmacology is rapidly evolving, with significant advancements in understanding the complex interactions between drugs and the immune system. The International Society for Immunopharmacology (ISI) has emerged as a leading global platform for scientists and researchers in this field, fostering collaboration, knowledge sharing, and the advancement of immunopharmacology research. This dissertation explores the invitation to join the ISI and its potential benefits for researchers and institutions, as well as the contributions of the society to the field of immunopharmacology. It delves into the resources, networking opportunities, conferences, and scientific publications provided by the ISI, highlighting the potential impact on individual researchers, institutions, and the field as a whole. The dissertation also examines the significance of joining the ISI in terms of global research collaborations, interdisciplinary approaches, and the dissemination of research findings. Through a comprehensive analysis of the invitation to join the ISI, this dissertation aims to provide insights into the advantages and opportunities associated with becoming a part of this esteemed international society.